Tag: CD38
Strategies for Treating Relapsed Multiple Myeloma After BCMA-Targeted CAR-T Therapy Failure
The techniques of modified T cell therapy known as CAR-T are considered the cornerstone of a new era in the treatment of cancerous tumors, especially multiple myeloma (MM). Clinical studies, particularly those focused on targeting the B-cell maturation antigen (BCMA), have shown remarkable efficacy in patients with relapsed or treatment-resistant multiple myeloma. However, the challenge…
Management of Multiple Myeloma Patients During Late-Stage Life and Analysis of Main Causes of Death
In recent years, new treatments for multiple myeloma (multiple myeloma syndrome) have made significant progress, giving hope to many patients. However, many patients still suffer from serious complications that ultimately lead to death. This article addresses a comprehensive study on how to manage patients in the advanced stages of the disease, by analyzing data from…